Related Experiment Video
Updated: Aug 1, 2026

Performing Behavioral Tasks in Subjects with Intracranial Electrodes
Published on: October 2, 2014
How to get patients with epilepsy to take their medication. The problem of noncompliance
1MINCEP Epilepsy Care, Minneapolis, MN 55416.
Abstract:
Noncompliance in patients with epilepsy is a serious hindrance to successful treatment. It can result in increased healthcare costs and put both the patients and others around them at unnecessary risk. Noncompliance should be considered whenever a patient has (1) an unexpected increase in number of severity of seizures, (2) serum levels of anticonvulsant medications below the expected range, or (3) a change in medical reimbursement systems. Effective intervention strategies are based on assessment of life-style issues and possible barriers to compliance. Communication with the patient about medication regimens and the value of treatment is extremely important, and a real partnership between physician and patient is needed to set and achieve goals.
More Related Videos
05:54Stereo-Electro-Encephalo-Graphy (SEEG) With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
07:01Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug Therapy
Antianxiety Medications